New study finds interferon-γ release assays more effective than skin tests in predicting tuberculosis

FHS
April 5, 2024
9:57 am

The performance of tuberculin skin test (TST) and interferon-γ release assays (IGRAs) in predicting tuberculosis (TB).

Vertex licenses Editas’ gene editing technology in $100m deal – Pharmaceutical Technology

Share this article Vertex will pay $50m to Editas upfront, with an additional contingent $50m payment. Image credit: Shutterstock/Catalin Rusnac. Vertex Pharmaceuticals has entered a

December 14, 2023

FDA official sets out approach to AI in medical devices

Dive Brief: Less than a week after the Food and Drug Administration published best practices for transparency in machine learning-enabled medical devices, a leader with

June 19, 2024

Mapping the human dysfunctome with deep brain stimulation

A new study led by investigators from Mass General Brigham demonstrated the use of deep brain stimulation (DBS) to map a ‘human dysfunctome’ -; a

February 23, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.